高压氧治疗20例克罗恩病肛周瘘管
本研究在阿姆斯特丹UMC纳入20例难治性肛周瘘管克罗恩病患者,给予40次高压氧治疗,第16周评估。肛周疾病活动指数和改良van Assche指数均显著下降,65%患者达到非活动状态,60%临床应答、20%临床缓解,CRP和粪钙卫蛋白也显著降低。
要点
- 高压氧可显著改善难治性肛周瘘管克罗恩病的临床和影像学指标
- 第16周65%患者肛周疾病活动指数≤4,60%临床应答、20%临床缓解
- CRP和粪钙卫蛋白在高压氧治疗后显著下降
核心结论
- 高压氧治疗使难治性肛周瘘管克罗恩病患者获得显著的临床、影像学和生化改善。
研究设计与样本
- 前瞻性研究,在阿姆斯特丹UMC肛瘘门诊连续纳入20例传统治疗超过6个月失败的高位肛周瘘管克罗恩病患者。
- 排除标准包括存在造口、直肠阴道瘘和近期治疗方案改变者。
- 患者接受40次高压氧治疗,第16周评估结局参数。
主要发现
- 肛周疾病活动指数中位数从7.5(95%CI 6-9)降至4(95%CI 3-6),P<0.001。
- 改良van Assche指数中位数从9.2(95%CI 7.3-11.2)降至7.3(95%CI 6.9-9.7),P=0.004。
- 13/20例(65%)患者肛周疾病活动指数≤4,代表肛周疾病非活动。
- CRP中位数从4.2 mg/mL(95%CI 1.6-8)降至2.2(95%CI 0.9-4.3),P=0.003;粪钙卫蛋白从399 µg/g(95%CI 52-922)降至31(95%CI 16-245),P=0.001。
临床怎么用
- 对于传统治疗失败的难治性肛周瘘管克罗恩病患者,高压氧可作为改善临床和生化指标的治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Positive effects of hyperbaric oxygen on perianal fistulas in Crohn's disease have been reported. AIM: To assess efficacy, safety and feasibility of hyperbaric oxygen in Crohn's disease patients with therapy-refractory perianal fistulas. METHODS: Twenty consecutive patients were recruited at the out-patient fistula clinic of the Amsterdam UMC. Crohn's disease patients with high perianal fistula(s) failing conventional treatment for over 6 months were included. Exclusion criteria were presence of a stoma, rectovaginal fistula(s) and recent changes in treatment regimens. Patients received treatment with 40 hyperbaric oxygen sessions and outcome parameters were assessed at Week 16. RESULTS: Seven women and 13 men were included (median age 34 years). At Week 16, median scores of perianal disease activity index and modified van Assche index (co-primary outcome parameters) decreased from 7.5 (95% CI 6-9) to 4 (95% CI 3-6, P < 0.001), and from 9.2 (95% CI 7.3-11.2) to 7.3 (95% CI 6.9-9.7, P = 0.004) respectively. Perianal disease activity index scores ≤4 (representing inactive perianal disease) were observed in 13/20 patients (65%). Twelve patients showed a clinical response (60%) and four (20%) clinical remission, assessed with fistula drainage assessment. Median C-reactive protein and faecal calprotectin levels decreased from 4.2 mg/mL (95% CI 1.6-8) to 2.2 (95% CI 0.9-4.3, P = 0.003) and from 399 µg/g (95% CI 52-922) to 31 (95% CI 16-245, P = 0.001), respectively. CONCLUSIONS: We found significant clinical, radiological and biochemical improvement in Crohn's disease patients with therapy-refractory perianal fistulas after treatment with hyperbaric oxygen. CLINICAL TRIAL REGISTRATION: www.trialregister.nl/trial/6489.
引用
- Lansdorp CA, Gecse KB, Buskens CJ, et al. Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease. Aliment Pharmacol Ther. 2020. PMID: 33326623. doi:10.1111/apt.16228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。